MUMBAI, Inde, 30 janvier 2025 /PRNewswire/ — Piramal Pharma Limited (NSE : PPLPHARMA) (BSE : 543635), l’un des leaders mondiaux de l’industrie pharmaceutique et du bien-être, a annoncé aujourd’hui ses résultats autonomes et consolidés pour le troisième trimestre (T3) et les neuf mois…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.